全文获取类型
收费全文 | 7377篇 |
免费 | 660篇 |
国内免费 | 20篇 |
专业分类
耳鼻咽喉 | 110篇 |
儿科学 | 221篇 |
妇产科学 | 124篇 |
基础医学 | 995篇 |
口腔科学 | 241篇 |
临床医学 | 662篇 |
内科学 | 1515篇 |
皮肤病学 | 155篇 |
神经病学 | 608篇 |
特种医学 | 322篇 |
外国民族医学 | 2篇 |
外科学 | 1013篇 |
综合类 | 87篇 |
预防医学 | 535篇 |
眼科学 | 146篇 |
药学 | 462篇 |
中国医学 | 32篇 |
肿瘤学 | 827篇 |
出版年
2023年 | 33篇 |
2022年 | 77篇 |
2021年 | 188篇 |
2020年 | 115篇 |
2019年 | 224篇 |
2018年 | 255篇 |
2017年 | 181篇 |
2016年 | 188篇 |
2015年 | 224篇 |
2014年 | 289篇 |
2013年 | 344篇 |
2012年 | 411篇 |
2011年 | 433篇 |
2010年 | 292篇 |
2009年 | 256篇 |
2008年 | 360篇 |
2007年 | 355篇 |
2006年 | 303篇 |
2005年 | 305篇 |
2004年 | 276篇 |
2003年 | 250篇 |
2002年 | 232篇 |
2001年 | 188篇 |
2000年 | 217篇 |
1999年 | 171篇 |
1998年 | 101篇 |
1997年 | 90篇 |
1996年 | 76篇 |
1995年 | 83篇 |
1994年 | 71篇 |
1993年 | 70篇 |
1992年 | 113篇 |
1991年 | 122篇 |
1990年 | 111篇 |
1989年 | 133篇 |
1988年 | 89篇 |
1987年 | 92篇 |
1986年 | 79篇 |
1985年 | 62篇 |
1984年 | 71篇 |
1983年 | 43篇 |
1982年 | 47篇 |
1981年 | 50篇 |
1980年 | 41篇 |
1979年 | 50篇 |
1978年 | 27篇 |
1977年 | 32篇 |
1976年 | 39篇 |
1974年 | 22篇 |
1971年 | 27篇 |
排序方式: 共有8057条查询结果,搜索用时 31 毫秒
51.
52.
Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. Clinical Inhaled Nitric Oxide Research Group 总被引:12,自引:0,他引:12
Clark RH Kueser TJ Walker MW Southgate WM Huckaby JL Perez JA Roy BJ Keszler M Kinsella JP 《The New England journal of medicine》2000,342(7):469-474
BACKGROUND: Inhaled nitric oxide improves gas exchange in neonates, but the efficacy of low-dose inhaled nitric oxide in reducing the need for extracorporeal membrane oxygenation has not been established. METHODS: We conducted a clinical trial to determine whether low-dose inhaled nitric oxide would reduce the use of extracorporeal membrane oxygenation in neonates with pulmonary hypertension who were born after 34 weeks' gestation, were 4 days old or younger, required assisted ventilation, and had hypoxemic respiratory failure as defined by an oxygenation index of 25 or higher. The neonates who received nitric oxide were treated with 20 ppm for a maximum of 24 hours, followed by 5 ppm for no more than 96 hours. The primary end point of the study was the use of extracorporeal membrane oxygenation. RESULTS: Of 248 neonates enrolled, 126 were randomly assigned to the nitric oxide group and 122 to the control group. Extracorporeal membrane oxygenation was used in 78 neonates in the control group (64 percent) and in 48 neonates in the nitric oxide group (38 percent) (P=0.001). The 30-day mortality rate in the two groups was similar (8 percent in the control group and 7 percent in the nitric oxide group). Chronic lung disease developed less often in neonates treated with nitric oxide than in those in the control group (7 percent vs. 20 percent, P=0.02). The efficacy of nitric oxide was independent of the base-line oxygenation index and the primary pulmonary diagnosis. CONCLUSIONS: Inhaled nitric oxide reduces the extent to which extracorporeal membrane oxygenation is needed in neonates with hypoxemic respiratory failure and pulmonary hypertension. 相似文献
53.
54.
Primm BJ Perez L Dennis GC Benjamin L Clark W Keough K Leak WD Payne R Smith D Sullivan LW;National Medical Association 《Journal of the National Medical Association》2004,96(9):1152-1161
ISSUE: Inadequate pain management is a serious public health problem that affects a wide cross-section of Americans. Patients are often denied sufficient medication, because physicians lack training and fear scrutiny from federal and state regulatory agencies. In addition, even the state-financed system of care, Medicaid, has been increasingly denying payment for the best treatment for pain management. These factors are complicated by physician bias about various subgroups and poor physician-patient communication. Comprehensive patient assessment plays a crucial role in determining appropriate treatment and identifying potential abuse problems. Physicians must routinely document medications analgesic effects and screen for potential ill effects and drug abuse. OBJECTIVE: To examine the prevalence of the undertreatment of pain, particularly among African Americans, and to recommend relevant proactive policy and practice changes to aid in eliminating this health problem. CONSENSUS PROCESS: In July 2002, the NMA convened the "Managing Pain: The Challenge in Underserved Populations: Appropriate Use versus Abuse and Diversion" Consensus Meeting in Washington, DC. The country's most renowned experts in the area of pain management and substance abuse reviewed substantial information regarding pain management and substance abuse including the following: --A draft summary paper on pain management and substance abuse that served as briefing material for consensus members; --Annotated bibliographies; --Articles on pain management and substance abuse; and --Key presentations on pain management and substance abuse. 相似文献
55.
Pneumonia due to Bordetella bronchiseptica in a cystic fibrosis patient: 16S rRNA sequencing for diagnosis confirmation 下载免费PDF全文
Wallet F Perez T Armand S Wallaert B Courcol RJ 《Journal of clinical microbiology》2002,40(6):2300-2301
Bordetella bronchiseptica was identified as an unusual etiologic agent of pulmonary recurrent exacerbations and pneumonia in a cystic fibrosis (CF) patient by utilizing a 16S rRNA molecular kit in our hospital's clinical laboratory. This method appears to be a useful approach for identifying new emerging CF pathogens when discrepancies exist between phenotypical tests. 相似文献
56.
57.
58.
A Villena V Requena F Diaz I Perez de Vargas 《Mechanisms of ageing and development》1991,57(3):275-282
Nuclear and cytoplasmic dLGN neurons were investigated by cytophotometric measurements of RNA. This study has been carried out in rats from birth to adulthood. In order to quantify the RNA content a cytophotometer was used. Extinction mean values were obtained which indicated RNA concentrations per surface unit. The nuclear and cytoplasmic surface were calculated simultaneously and from the product of the mean extinction and the surface the RNA total content was calculated. Our results have suggested that the changes are age-related. From day 1 to day 21 the neuronal size and RNA content increase; this may somehow be involved with the differentiation process. Around post-natal day 21 neuronal maturation may begin, reaching its optimal phase around day 42, on which the RNA concentration per surface unit, surface neuronal content and RNA total content are stable. 相似文献
59.
Louise Bergeron Gloria I. Perez Glen Macdonald Lianfa Shi Yi Sun Andrea Jurisicova Sue Varmuza Keith E. Latham Jodi A. Flaws Jessica C.M. Salter Hideaki Hara Michael A. Moskowitz En Li Arnold Greenberg Jonathan L. Tilly Junying Yuan 《Genes & development》1998,12(9):1304-1314
During embryonic development, a large number of cells die naturally to shape the new organism. Members of the caspase family of proteases are essential intracellular death effectors. Herein, we generated caspase-2-deficient mice to evaluate the requirement for this enzyme in various paradigms of apoptosis. Excess numbers of germ cells were endowed in ovaries of mutant mice and the oocytes were found to be resistant to cell death following exposure to chemotherapeutic drugs. Apoptosis mediated by granzyme B and perforin was defective in caspase-2-deficient B lymphoblasts. In contrast, cell death of motor neurons during development was accelerated in caspase-2-deficient mice. In addition, caspase-2-deficient sympathetic neurons underwent apoptosis more effectively than wild-type neurons when deprived of NGF. Thus, caspase-2 acts both as a positive and negative cell death effector, depending upon cell lineage and stage of development. 相似文献
60.
Avilion AA Nicolis SK Pevny LH Perez L Vivian N Lovell-Badge R 《Genes & development》2003,17(1):126-140